Coverage of recommended vaccines during pregnancy in Flanders, Belgium. Fairly good but can we do better?
Identifieur interne : 000011 ( Main/Exploration ); précédent : 000010; suivant : 000012Coverage of recommended vaccines during pregnancy in Flanders, Belgium. Fairly good but can we do better?
Auteurs : Kirsten Maertens [Belgique] ; Tessa Braeckman [Belgique] ; Stéphanie Blaizot [Belgique] ; Heidi Theeten [Belgique] ; Mathieu Roelants [Belgique] ; Karel Hoppenbrouwers [Belgique] ; Elke Leuridan [Belgique] ; Pierre Van Damme [Belgique] ; Corinne Vandermeulen [Belgique]Source :
- Vaccine [ 1873-2518 ] ; 2018.
Descripteurs français
- KwdFr :
- Adulte, Belgique, Complications infectieuses de la grossesse (prévention et contrôle), Couverture vaccinale (statistiques et données numériques), Enquêtes de santé, Facteurs socioéconomiques, Femelle, Femmes enceintes, Grossesse, Humains, Programmes de vaccination, Période du postpartum, Vaccin anticoquelucheux (usage thérapeutique), Vaccins antigrippaux (usage thérapeutique).
- MESH :
- prévention et contrôle : Complications infectieuses de la grossesse.
- statistiques et données numériques : Couverture vaccinale.
- usage thérapeutique : Vaccin anticoquelucheux, Vaccins antigrippaux.
- Adulte, Belgique, Enquêtes de santé, Facteurs socioéconomiques, Femelle, Femmes enceintes, Grossesse, Humains, Programmes de vaccination, Période du postpartum.
English descriptors
- KwdEn :
- Adult, Belgium, Female, Health Surveys, Humans, Immunization Programs, Influenza Vaccines (therapeutic use), Pertussis Vaccine (therapeutic use), Postpartum Period, Pregnancy, Pregnancy Complications, Infectious (prevention & control), Pregnant Women, Socioeconomic Factors, Vaccination Coverage (statistics & numerical data).
- MESH :
- chemical , therapeutic use : Influenza Vaccines, Pertussis Vaccine.
- prevention & control : Pregnancy Complications, Infectious.
- statistics & numerical data : Vaccination Coverage.
- Adult, Belgium, Female, Health Surveys, Humans, Immunization Programs, Postpartum Period, Pregnancy, Pregnant Women, Socioeconomic Factors.
Abstract
BACKGROUND
In Flanders, Belgium, pertussis vaccination is recommended since 2013 and available free-of-charge in every pregnancy between 24 and 32 weeks of gestation. Influenza vaccination is recommended for more than 10 years with a co-payment system in the second or third trimester of pregnancy, when pregnancy coincides with the influenza season. This study aims to estimate the coverage of pertussis and influenza vaccination during pregnancy in 2016 and to determine predictors for missing vaccination.
METHODS
Postpartum women were visited at home for a vaccination coverage survey using an Expanded Program on Immunization (EPI)-based two-stage cluster sampling design. Predictors for missed vaccination were identified using a multiple logistic regression model.
RESULTS
Among 481 participating women, 69.3% were vaccinated against pertussis and 47.2% were vaccinated against influenza. Moreover, 65.3% of pertussis vaccine recipients and 96.9% of influenza vaccine recipients were vaccinated within the recommended gestational window. Surprisingly, among women who were completely informed (i.e. on disease-associated risks, maternal vaccination costs and recommendations), still 12.4% were unvaccinated against pertussis and 23.9% against influenza. In the final models, the only common predictor of missing maternal pertussis and influenza vaccination was multiparity. Significant predictors of maternal pertussis vaccination were family income (less likely if unknown or low (< €3000) than if moderate (€3001-€4000)) and hospital of delivery (less likely if >800 annual deliveries than <800). Significant predictors of maternal influenza vaccination, though with less straight-forward associations, were maternal ethnicity and educational level, involvement of a gynaecologist in pregnancy follow-up, and characteristics of the hospital of delivery.
CONCLUSION
In Flanders, more than two-third of pregnant women receives pertussis vaccination but less than half of them receives the influenza vaccine. Further improvement for both maternal vaccination programs can be achieved by targeting the underserved populations and diminishing vaccination hurdles.
DOI: 10.1016/j.vaccine.2018.03.033
PubMed: 29627238
Affiliations:
- Belgique
- Province d'Anvers, Province du Brabant flamand, Région flamande
- Anvers, Louvain
- Université d'Anvers
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Coverage of recommended vaccines during pregnancy in Flanders, Belgium. Fairly good but can we do better?</title><author><name sortKey="Maertens, Kirsten" sort="Maertens, Kirsten" uniqKey="Maertens K" first="Kirsten" last="Maertens">Kirsten Maertens</name><affiliation wicri:level="4"><nlm:affiliation>Centre for the Evaluation of Vaccination, VAXINFECTIO, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium. Electronic address: kirsten.maertens@uantwerp.be.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Centre for the Evaluation of Vaccination, VAXINFECTIO, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk</wicri:regionArea><orgName type="university">Université d'Anvers</orgName><placeName><settlement type="city">Anvers</settlement><region>Région flamande</region><region type="district" nuts="2">Province d'Anvers</region></placeName></affiliation></author><author><name sortKey="Braeckman, Tessa" sort="Braeckman, Tessa" uniqKey="Braeckman T" first="Tessa" last="Braeckman">Tessa Braeckman</name><affiliation wicri:level="4"><nlm:affiliation>Centre for the Evaluation of Vaccination, VAXINFECTIO, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Centre for the Evaluation of Vaccination, VAXINFECTIO, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk</wicri:regionArea><orgName type="university">Université d'Anvers</orgName><placeName><settlement type="city">Anvers</settlement><region>Région flamande</region><region type="district" nuts="2">Province d'Anvers</region></placeName></affiliation></author><author><name sortKey="Blaizot, Stephanie" sort="Blaizot, Stephanie" uniqKey="Blaizot S" first="Stéphanie" last="Blaizot">Stéphanie Blaizot</name><affiliation wicri:level="4"><nlm:affiliation>Centre for Health Economics Research and Modelling Infectious Diseases, VAXINFECTIO, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Centre for Health Economics Research and Modelling Infectious Diseases, VAXINFECTIO, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk</wicri:regionArea><orgName type="university">Université d'Anvers</orgName><placeName><settlement type="city">Anvers</settlement><region>Région flamande</region><region type="district" nuts="2">Province d'Anvers</region></placeName></affiliation></author><author><name sortKey="Theeten, Heidi" sort="Theeten, Heidi" uniqKey="Theeten H" first="Heidi" last="Theeten">Heidi Theeten</name><affiliation wicri:level="4"><nlm:affiliation>Centre for the Evaluation of Vaccination, VAXINFECTIO, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Centre for the Evaluation of Vaccination, VAXINFECTIO, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk</wicri:regionArea><orgName type="university">Université d'Anvers</orgName><placeName><settlement type="city">Anvers</settlement><region>Région flamande</region><region type="district" nuts="2">Province d'Anvers</region></placeName></affiliation></author><author><name sortKey="Roelants, Mathieu" sort="Roelants, Mathieu" uniqKey="Roelants M" first="Mathieu" last="Roelants">Mathieu Roelants</name><affiliation wicri:level="3"><nlm:affiliation>Environment and Health, KU Leuven, Kapucijnenvoer 35 blok d, 3000 Leuven, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Environment and Health, KU Leuven, Kapucijnenvoer 35 blok d, 3000 Leuven</wicri:regionArea><placeName><region type="province" nuts="2">Province du Brabant flamand</region><settlement type="city">Louvain</settlement></placeName></affiliation></author><author><name sortKey="Hoppenbrouwers, Karel" sort="Hoppenbrouwers, Karel" uniqKey="Hoppenbrouwers K" first="Karel" last="Hoppenbrouwers">Karel Hoppenbrouwers</name><affiliation wicri:level="3"><nlm:affiliation>Environment and Health, KU Leuven, Kapucijnenvoer 35 blok d, 3000 Leuven, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Environment and Health, KU Leuven, Kapucijnenvoer 35 blok d, 3000 Leuven</wicri:regionArea><placeName><region type="province" nuts="2">Province du Brabant flamand</region><settlement type="city">Louvain</settlement></placeName></affiliation></author><author><name sortKey="Leuridan, Elke" sort="Leuridan, Elke" uniqKey="Leuridan E" first="Elke" last="Leuridan">Elke Leuridan</name><affiliation wicri:level="4"><nlm:affiliation>Centre for the Evaluation of Vaccination, VAXINFECTIO, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Centre for the Evaluation of Vaccination, VAXINFECTIO, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk</wicri:regionArea><orgName type="university">Université d'Anvers</orgName><placeName><settlement type="city">Anvers</settlement><region>Région flamande</region><region type="district" nuts="2">Province d'Anvers</region></placeName></affiliation></author><author><name sortKey="Van Damme, Pierre" sort="Van Damme, Pierre" uniqKey="Van Damme P" first="Pierre" last="Van Damme">Pierre Van Damme</name><affiliation wicri:level="4"><nlm:affiliation>Centre for the Evaluation of Vaccination, VAXINFECTIO, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Centre for the Evaluation of Vaccination, VAXINFECTIO, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk</wicri:regionArea><orgName type="university">Université d'Anvers</orgName><placeName><settlement type="city">Anvers</settlement><region>Région flamande</region><region type="district" nuts="2">Province d'Anvers</region></placeName></affiliation></author><author><name sortKey="Vandermeulen, Corinne" sort="Vandermeulen, Corinne" uniqKey="Vandermeulen C" first="Corinne" last="Vandermeulen">Corinne Vandermeulen</name><affiliation wicri:level="3"><nlm:affiliation>Leuven University Vaccinology Center, KU Leuven, Campus Gasthuisberg, Herestraat 49, 3000 Leuven, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Leuven University Vaccinology Center, KU Leuven, Campus Gasthuisberg, Herestraat 49, 3000 Leuven</wicri:regionArea><placeName><region type="province" nuts="2">Province du Brabant flamand</region><settlement type="city">Louvain</settlement></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2018">2018</date><idno type="RBID">pubmed:29627238</idno><idno type="pmid">29627238</idno><idno type="doi">10.1016/j.vaccine.2018.03.033</idno><idno type="wicri:Area/Main/Corpus">000012</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000012</idno><idno type="wicri:Area/Main/Curation">000012</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000012</idno><idno type="wicri:Area/Main/Exploration">000012</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Coverage of recommended vaccines during pregnancy in Flanders, Belgium. Fairly good but can we do better?</title><author><name sortKey="Maertens, Kirsten" sort="Maertens, Kirsten" uniqKey="Maertens K" first="Kirsten" last="Maertens">Kirsten Maertens</name><affiliation wicri:level="4"><nlm:affiliation>Centre for the Evaluation of Vaccination, VAXINFECTIO, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium. Electronic address: kirsten.maertens@uantwerp.be.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Centre for the Evaluation of Vaccination, VAXINFECTIO, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk</wicri:regionArea><orgName type="university">Université d'Anvers</orgName><placeName><settlement type="city">Anvers</settlement><region>Région flamande</region><region type="district" nuts="2">Province d'Anvers</region></placeName></affiliation></author><author><name sortKey="Braeckman, Tessa" sort="Braeckman, Tessa" uniqKey="Braeckman T" first="Tessa" last="Braeckman">Tessa Braeckman</name><affiliation wicri:level="4"><nlm:affiliation>Centre for the Evaluation of Vaccination, VAXINFECTIO, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Centre for the Evaluation of Vaccination, VAXINFECTIO, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk</wicri:regionArea><orgName type="university">Université d'Anvers</orgName><placeName><settlement type="city">Anvers</settlement><region>Région flamande</region><region type="district" nuts="2">Province d'Anvers</region></placeName></affiliation></author><author><name sortKey="Blaizot, Stephanie" sort="Blaizot, Stephanie" uniqKey="Blaizot S" first="Stéphanie" last="Blaizot">Stéphanie Blaizot</name><affiliation wicri:level="4"><nlm:affiliation>Centre for Health Economics Research and Modelling Infectious Diseases, VAXINFECTIO, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Centre for Health Economics Research and Modelling Infectious Diseases, VAXINFECTIO, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk</wicri:regionArea><orgName type="university">Université d'Anvers</orgName><placeName><settlement type="city">Anvers</settlement><region>Région flamande</region><region type="district" nuts="2">Province d'Anvers</region></placeName></affiliation></author><author><name sortKey="Theeten, Heidi" sort="Theeten, Heidi" uniqKey="Theeten H" first="Heidi" last="Theeten">Heidi Theeten</name><affiliation wicri:level="4"><nlm:affiliation>Centre for the Evaluation of Vaccination, VAXINFECTIO, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Centre for the Evaluation of Vaccination, VAXINFECTIO, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk</wicri:regionArea><orgName type="university">Université d'Anvers</orgName><placeName><settlement type="city">Anvers</settlement><region>Région flamande</region><region type="district" nuts="2">Province d'Anvers</region></placeName></affiliation></author><author><name sortKey="Roelants, Mathieu" sort="Roelants, Mathieu" uniqKey="Roelants M" first="Mathieu" last="Roelants">Mathieu Roelants</name><affiliation wicri:level="3"><nlm:affiliation>Environment and Health, KU Leuven, Kapucijnenvoer 35 blok d, 3000 Leuven, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Environment and Health, KU Leuven, Kapucijnenvoer 35 blok d, 3000 Leuven</wicri:regionArea><placeName><region type="province" nuts="2">Province du Brabant flamand</region><settlement type="city">Louvain</settlement></placeName></affiliation></author><author><name sortKey="Hoppenbrouwers, Karel" sort="Hoppenbrouwers, Karel" uniqKey="Hoppenbrouwers K" first="Karel" last="Hoppenbrouwers">Karel Hoppenbrouwers</name><affiliation wicri:level="3"><nlm:affiliation>Environment and Health, KU Leuven, Kapucijnenvoer 35 blok d, 3000 Leuven, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Environment and Health, KU Leuven, Kapucijnenvoer 35 blok d, 3000 Leuven</wicri:regionArea><placeName><region type="province" nuts="2">Province du Brabant flamand</region><settlement type="city">Louvain</settlement></placeName></affiliation></author><author><name sortKey="Leuridan, Elke" sort="Leuridan, Elke" uniqKey="Leuridan E" first="Elke" last="Leuridan">Elke Leuridan</name><affiliation wicri:level="4"><nlm:affiliation>Centre for the Evaluation of Vaccination, VAXINFECTIO, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Centre for the Evaluation of Vaccination, VAXINFECTIO, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk</wicri:regionArea><orgName type="university">Université d'Anvers</orgName><placeName><settlement type="city">Anvers</settlement><region>Région flamande</region><region type="district" nuts="2">Province d'Anvers</region></placeName></affiliation></author><author><name sortKey="Van Damme, Pierre" sort="Van Damme, Pierre" uniqKey="Van Damme P" first="Pierre" last="Van Damme">Pierre Van Damme</name><affiliation wicri:level="4"><nlm:affiliation>Centre for the Evaluation of Vaccination, VAXINFECTIO, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Centre for the Evaluation of Vaccination, VAXINFECTIO, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk</wicri:regionArea><orgName type="university">Université d'Anvers</orgName><placeName><settlement type="city">Anvers</settlement><region>Région flamande</region><region type="district" nuts="2">Province d'Anvers</region></placeName></affiliation></author><author><name sortKey="Vandermeulen, Corinne" sort="Vandermeulen, Corinne" uniqKey="Vandermeulen C" first="Corinne" last="Vandermeulen">Corinne Vandermeulen</name><affiliation wicri:level="3"><nlm:affiliation>Leuven University Vaccinology Center, KU Leuven, Campus Gasthuisberg, Herestraat 49, 3000 Leuven, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Leuven University Vaccinology Center, KU Leuven, Campus Gasthuisberg, Herestraat 49, 3000 Leuven</wicri:regionArea><placeName><region type="province" nuts="2">Province du Brabant flamand</region><settlement type="city">Louvain</settlement></placeName></affiliation></author></analytic><series><title level="j">Vaccine</title><idno type="eISSN">1873-2518</idno><imprint><date when="2018" type="published">2018</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Belgium</term><term>Female</term><term>Health Surveys</term><term>Humans</term><term>Immunization Programs</term><term>Influenza Vaccines (therapeutic use)</term><term>Pertussis Vaccine (therapeutic use)</term><term>Postpartum Period</term><term>Pregnancy</term><term>Pregnancy Complications, Infectious (prevention & control)</term><term>Pregnant Women</term><term>Socioeconomic Factors</term><term>Vaccination Coverage (statistics & numerical data)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Belgique</term><term>Complications infectieuses de la grossesse (prévention et contrôle)</term><term>Couverture vaccinale (statistiques et données numériques)</term><term>Enquêtes de santé</term><term>Facteurs socioéconomiques</term><term>Femelle</term><term>Femmes enceintes</term><term>Grossesse</term><term>Humains</term><term>Programmes de vaccination</term><term>Période du postpartum</term><term>Vaccin anticoquelucheux (usage thérapeutique)</term><term>Vaccins antigrippaux (usage thérapeutique)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Influenza Vaccines</term><term>Pertussis Vaccine</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Pregnancy Complications, Infectious</term></keywords><keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr"><term>Complications infectieuses de la grossesse</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Vaccination Coverage</term></keywords><keywords scheme="MESH" qualifier="statistiques et données numériques" xml:lang="fr"><term>Couverture vaccinale</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Vaccin anticoquelucheux</term><term>Vaccins antigrippaux</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Belgium</term><term>Female</term><term>Health Surveys</term><term>Humans</term><term>Immunization Programs</term><term>Postpartum Period</term><term>Pregnancy</term><term>Pregnant Women</term><term>Socioeconomic Factors</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Belgique</term><term>Enquêtes de santé</term><term>Facteurs socioéconomiques</term><term>Femelle</term><term>Femmes enceintes</term><term>Grossesse</term><term>Humains</term><term>Programmes de vaccination</term><term>Période du postpartum</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>BACKGROUND</b></p><p>In Flanders, Belgium, pertussis vaccination is recommended since 2013 and available free-of-charge in every pregnancy between 24 and 32 weeks of gestation. Influenza vaccination is recommended for more than 10 years with a co-payment system in the second or third trimester of pregnancy, when pregnancy coincides with the influenza season. This study aims to estimate the coverage of pertussis and influenza vaccination during pregnancy in 2016 and to determine predictors for missing vaccination.</p></div><div type="abstract" xml:lang="en"><p><b>METHODS</b></p><p>Postpartum women were visited at home for a vaccination coverage survey using an Expanded Program on Immunization (EPI)-based two-stage cluster sampling design. Predictors for missed vaccination were identified using a multiple logistic regression model.</p></div><div type="abstract" xml:lang="en"><p><b>RESULTS</b></p><p>Among 481 participating women, 69.3% were vaccinated against pertussis and 47.2% were vaccinated against influenza. Moreover, 65.3% of pertussis vaccine recipients and 96.9% of influenza vaccine recipients were vaccinated within the recommended gestational window. Surprisingly, among women who were completely informed (i.e. on disease-associated risks, maternal vaccination costs and recommendations), still 12.4% were unvaccinated against pertussis and 23.9% against influenza. In the final models, the only common predictor of missing maternal pertussis and influenza vaccination was multiparity. Significant predictors of maternal pertussis vaccination were family income (less likely if unknown or low (< €3000) than if moderate (€3001-€4000)) and hospital of delivery (less likely if >800 annual deliveries than <800). Significant predictors of maternal influenza vaccination, though with less straight-forward associations, were maternal ethnicity and educational level, involvement of a gynaecologist in pregnancy follow-up, and characteristics of the hospital of delivery.</p></div><div type="abstract" xml:lang="en"><p><b>CONCLUSION</b></p><p>In Flanders, more than two-third of pregnant women receives pertussis vaccination but less than half of them receives the influenza vaccine. Further improvement for both maternal vaccination programs can be achieved by targeting the underserved populations and diminishing vaccination hurdles.</p></div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29627238</PMID><DateCompleted><Year>2018</Year><Month>12</Month><Day>11</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-2518</ISSN><JournalIssue CitedMedium="Internet"><Volume>36</Volume><Issue>19</Issue><PubDate><Year>2018</Year><Month>05</Month><Day>03</Day></PubDate></JournalIssue><Title>Vaccine</Title><ISOAbbreviation>Vaccine</ISOAbbreviation></Journal><ArticleTitle>Coverage of recommended vaccines during pregnancy in Flanders, Belgium. Fairly good but can we do better?</ArticleTitle><Pagination><MedlinePgn>2687-2693</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0264-410X(18)30378-5</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.vaccine.2018.03.033</ELocationID><Abstract><AbstractText Label="BACKGROUND">In Flanders, Belgium, pertussis vaccination is recommended since 2013 and available free-of-charge in every pregnancy between 24 and 32 weeks of gestation. Influenza vaccination is recommended for more than 10 years with a co-payment system in the second or third trimester of pregnancy, when pregnancy coincides with the influenza season. This study aims to estimate the coverage of pertussis and influenza vaccination during pregnancy in 2016 and to determine predictors for missing vaccination.</AbstractText><AbstractText Label="METHODS">Postpartum women were visited at home for a vaccination coverage survey using an Expanded Program on Immunization (EPI)-based two-stage cluster sampling design. Predictors for missed vaccination were identified using a multiple logistic regression model.</AbstractText><AbstractText Label="RESULTS">Among 481 participating women, 69.3% were vaccinated against pertussis and 47.2% were vaccinated against influenza. Moreover, 65.3% of pertussis vaccine recipients and 96.9% of influenza vaccine recipients were vaccinated within the recommended gestational window. Surprisingly, among women who were completely informed (i.e. on disease-associated risks, maternal vaccination costs and recommendations), still 12.4% were unvaccinated against pertussis and 23.9% against influenza. In the final models, the only common predictor of missing maternal pertussis and influenza vaccination was multiparity. Significant predictors of maternal pertussis vaccination were family income (less likely if unknown or low (< €3000) than if moderate (€3001-€4000)) and hospital of delivery (less likely if >800 annual deliveries than <800). Significant predictors of maternal influenza vaccination, though with less straight-forward associations, were maternal ethnicity and educational level, involvement of a gynaecologist in pregnancy follow-up, and characteristics of the hospital of delivery.</AbstractText><AbstractText Label="CONCLUSION">In Flanders, more than two-third of pregnant women receives pertussis vaccination but less than half of them receives the influenza vaccine. Further improvement for both maternal vaccination programs can be achieved by targeting the underserved populations and diminishing vaccination hurdles.</AbstractText><CopyrightInformation>Copyright © 2018 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Maertens</LastName><ForeName>Kirsten</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Centre for the Evaluation of Vaccination, VAXINFECTIO, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium. Electronic address: kirsten.maertens@uantwerp.be.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Braeckman</LastName><ForeName>Tessa</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Centre for the Evaluation of Vaccination, VAXINFECTIO, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blaizot</LastName><ForeName>Stéphanie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Centre for Health Economics Research and Modelling Infectious Diseases, VAXINFECTIO, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Theeten</LastName><ForeName>Heidi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Centre for the Evaluation of Vaccination, VAXINFECTIO, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roelants</LastName><ForeName>Mathieu</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Environment and Health, KU Leuven, Kapucijnenvoer 35 blok d, 3000 Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoppenbrouwers</LastName><ForeName>Karel</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Environment and Health, KU Leuven, Kapucijnenvoer 35 blok d, 3000 Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leuridan</LastName><ForeName>Elke</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Centre for the Evaluation of Vaccination, VAXINFECTIO, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Damme</LastName><ForeName>Pierre</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Centre for the Evaluation of Vaccination, VAXINFECTIO, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vandermeulen</LastName><ForeName>Corinne</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Leuven University Vaccinology Center, KU Leuven, Campus Gasthuisberg, Herestraat 49, 3000 Leuven, Belgium.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>04</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Vaccine</MedlineTA><NlmUniqueID>8406899</NlmUniqueID><ISSNLinking>0264-410X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010567">Pertussis Vaccine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001530" MajorTopicYN="N">Belgium</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006306" MajorTopicYN="N">Health Surveys</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017589" MajorTopicYN="N">Immunization Programs</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010567" MajorTopicYN="N">Pertussis Vaccine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D049590" MajorTopicYN="N">Postpartum Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011251" MajorTopicYN="N">Pregnancy Complications, Infectious</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D037841" MajorTopicYN="N">Pregnant Women</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012959" MajorTopicYN="N">Socioeconomic Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073887" MajorTopicYN="N">Vaccination Coverage</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Influenza</Keyword><Keyword MajorTopicYN="Y">Pregnancy</Keyword><Keyword MajorTopicYN="Y">Survey</Keyword><Keyword MajorTopicYN="Y">Tetanus-Diphtheria-Acellular Pertussis</Keyword><Keyword MajorTopicYN="Y">Vaccination coverage</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>10</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>03</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>03</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>4</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>12</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>4</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29627238</ArticleId><ArticleId IdType="pii">S0264-410X(18)30378-5</ArticleId><ArticleId IdType="doi">10.1016/j.vaccine.2018.03.033</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Belgique</li></country><region><li>Province d'Anvers</li><li>Province du Brabant flamand</li><li>Région flamande</li></region><settlement><li>Anvers</li><li>Louvain</li></settlement><orgName><li>Université d'Anvers</li></orgName></list><tree><country name="Belgique"><region name="Région flamande"><name sortKey="Maertens, Kirsten" sort="Maertens, Kirsten" uniqKey="Maertens K" first="Kirsten" last="Maertens">Kirsten Maertens</name></region><name sortKey="Blaizot, Stephanie" sort="Blaizot, Stephanie" uniqKey="Blaizot S" first="Stéphanie" last="Blaizot">Stéphanie Blaizot</name><name sortKey="Braeckman, Tessa" sort="Braeckman, Tessa" uniqKey="Braeckman T" first="Tessa" last="Braeckman">Tessa Braeckman</name><name sortKey="Hoppenbrouwers, Karel" sort="Hoppenbrouwers, Karel" uniqKey="Hoppenbrouwers K" first="Karel" last="Hoppenbrouwers">Karel Hoppenbrouwers</name><name sortKey="Leuridan, Elke" sort="Leuridan, Elke" uniqKey="Leuridan E" first="Elke" last="Leuridan">Elke Leuridan</name><name sortKey="Roelants, Mathieu" sort="Roelants, Mathieu" uniqKey="Roelants M" first="Mathieu" last="Roelants">Mathieu Roelants</name><name sortKey="Theeten, Heidi" sort="Theeten, Heidi" uniqKey="Theeten H" first="Heidi" last="Theeten">Heidi Theeten</name><name sortKey="Van Damme, Pierre" sort="Van Damme, Pierre" uniqKey="Van Damme P" first="Pierre" last="Van Damme">Pierre Van Damme</name><name sortKey="Vandermeulen, Corinne" sort="Vandermeulen, Corinne" uniqKey="Vandermeulen C" first="Corinne" last="Vandermeulen">Corinne Vandermeulen</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeBelgiqueV5/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000011 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000011 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= GrippeBelgiqueV5
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:29627238
|texte= Coverage of recommended vaccines during pregnancy in Flanders, Belgium. Fairly good but can we do better?
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:29627238" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippeBelgiqueV5
| This area was generated with Dilib version V0.6.35. |  |